ENT-001

N/A

Report date: 2024/01/29 15:08:48

Base Information

Drug NameENT-001
Drug Alias NameEnt-001ENT-001Ent001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInsulin-like growth factor-binding protein 3 receptor inhibitorsInsulin-like growth factor binding protein III inhibitors
TargetsInsulin-like growth factor-binding protein 3 receptorInsulin-like growth factor binding protein III
Therapy Area/IndicationsDiabetes Mellitus, Type 1Inflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOspedale San Raffaele
China Registration ClassN/A

Develop Information

Active CompaniesEnthera SRL
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Inflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A